Virbac S.A.

Virbac S.A. is a leading pharmaceutical company dedicated exclusively to animal health. Established in 1968 by French veterinarian Pierre-Richard Dick, the company has built a global presence, serving veterinarians, farmers, and pet owners in over 100 countries. Virbac develops, manufactures, and markets a comprehensive portfolio of products, including vaccines, antibiotics, parasiticides, dental care items, nutritional supplements, diagnostics, anti-inflammatory, and dermatological treatments. These solutions are designed to address a wide range of health needs for both companion animals and livestock. Notably, Virbac invests heavily in research and development, consistently introducing innovative therapies—such as recent antimicrobial-free treatments for canine conditions and licensed therapeutic antibodies for canine diseases—to improve animal well-being. Headquartered in Carros Cedex, France, Virbac operates manufacturing and R&D centers worldwide and stands as the world’s sixth largest veterinary biopharma group, recognized for its independent ethos and commitment to advancing global animal health.